✦ LIBER ✦
Combination of rituximab with blinatumomab (MT103/MEDI-538), a T cell-engaging CD19-/CD3-bispecific antibody, for highly efficient lysis of human B lymphoma cells
✍ Scribed by Sandrine d’Argouges; Sandra Wissing; Christian Brandl; Nadja Prang; Ralf Lutterbuese; Alex Kozhich; JoAnn Suzich; Mathias Locher; Peter Kiener; Peter Kufer; Robert Hofmeister; Patrick A. Baeuerle; Ralf C. Bargou
- Book ID
- 104040831
- Publisher
- Elsevier Science
- Year
- 2009
- Tongue
- English
- Weight
- 815 KB
- Volume
- 33
- Category
- Article
- ISSN
- 0145-2126
No coin nor oath required. For personal study only.